… Of the cytokine and growth factor agents studied for oral mucositis, the evidence only supports
use of … Additional well-designed research is needed on other cytokine and growth factor …

… of growth factors and cytokines for the prevention and/or treatment of oral mucositis (OM). …
the use of palifermin, a human recombinant keratinocyte growth factor (KGF-1) to prevent OM …

… growth factors may help the regeneration of cells lining of the mouth, thus preventing or
reducing oral mucositis … of cytokines and growth factors for preventing oral mucositis in patients …

… From the second review, a guideline could be presented recommending the use of
recombinant human keratinocyte growth factor-1 (palifermin) to prevent oral mucositis in patients …

… attempts to highlight the role of growth factors in the management of oral mucositis. … of
growth factors in treating oral mucositis. However, there are numerous families of growth factors, …

… oral mucositis led to poor oral intake and that delayed healing may end in death. We also
showed that orally … exposure in the oral cavity of rats, enhancing the recovery of oral mucosa. …

… growth factor (rhEGF) in head and neck cancer and lymphoma patients with irradiation (with
or without combined chemotherapy-induced oral mucositis… developed severe oral mucositis (…

… growth factors have elevated oral mucositis to a prominent toxicity of cancer therapy. A
contemporary model for mucositis … Oral mucositis has long been associated with intensive cancer …

… Mucositis is a complication of cancer therapy where impairment of the regenerative capacity
… Keratinocyte growth factor (KGF) is an epithelial cellspecific growth and differentiation factor …

… of bioactive/growth factors, hormones or interleukins to modify epithelial metabolism and
reduce the susceptibility of the tract to mucositis. … is likely to reduce the severity of oral mucositis. …